SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-22-023703
Filing Date
2022-10-06
Accepted
2022-10-05 18:00:59
Documents
96
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K cbli20211231_10k.htm   iXBRL 10-K 2314903
2 EXHIBIT 21.1 ex_320189.htm EX-21.1 7510
3 EXHIBIT 23.1 ex_320190.htm EX-23.1 2742
4 EXHIBIT 31.1 ex_320191.htm EX-31.1 10227
5 EXHIBIT 31.2 ex_350077.htm EX-31.2 10914
6 EXHIBIT 32.1 ex_320192.htm EX-32.1 9019
12 cbli01.jpg GRAPHIC 65935
13 devpipelinerevised.jpg GRAPHIC 80311
  Complete submission text file 0001437749-22-023703.txt   9142862

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA stab-20211231.xsd EX-101.SCH 88803
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stab-20211231_cal.xml EX-101.CAL 68714
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stab-20211231_def.xml EX-101.DEF 582229
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE stab-20211231_lab.xml EX-101.LAB 519963
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stab-20211231_pre.xml EX-101.PRE 624495
90 EXTRACTED XBRL INSTANCE DOCUMENT cbli20211231_10k_htm.xml XML 937266
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32954 | Film No.: 221296666
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences